Meghmani Organics Ltd is Rated Sell

1 hour ago
share
Share Via
Meghmani Organics Ltd is rated Sell by MarketsMojo, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Meghmani Organics Ltd is Rated Sell

Current Rating and Its Significance

The current Sell rating for Meghmani Organics Ltd indicates a cautious stance for investors. This rating suggests that the stock is expected to underperform relative to the broader market or its sector peers in the near to medium term. Investors are advised to consider this recommendation carefully, weighing the company’s financial health, valuation, and technical outlook before making investment decisions.

How Meghmani Organics Looks Today: Quality Assessment

As of 14 August 2026, Meghmani Organics exhibits a below-average quality grade. The company’s long-term fundamental strength remains weak, with a compounded annual growth rate (CAGR) of operating profits declining by approximately 19.46% over the past five years. This negative growth trend highlights challenges in sustaining profitability and operational efficiency. Additionally, the average return on equity (ROE) stands at a modest 7.13%, signalling limited profitability generated from shareholders’ funds. Such metrics suggest that the company faces structural or competitive pressures that constrain its ability to deliver robust earnings growth.

Valuation: Attractive but With Caveats

Despite the concerns around quality, Meghmani Organics currently holds an attractive valuation grade. This implies that, relative to its earnings, assets, or cash flows, the stock is priced favourably compared to its historical levels or sector benchmarks. For value-oriented investors, this could represent a potential opportunity to acquire shares at a discount. However, the attractive valuation must be balanced against the company’s fundamental challenges and market risks, which may limit upside potential in the near term.

Financial Trend: Positive Momentum Amidst Challenges

The financial grade for Meghmani Organics is very positive, reflecting recent improvements in key financial indicators. The stock has shown notable short-term price appreciation, with returns of +6.29% in the last day, +17.11% over the past week, and +30.64% in the last month. However, the year-to-date (YTD) return remains negative at -4.29%, and the one-year return is down by -26.36%, indicating volatility and underperformance over longer horizons. The positive financial trend suggests some recovery or market interest, but investors should remain cautious given the broader context of inconsistent returns and underlying business challenges.

Technicals: Mildly Bearish Outlook

From a technical perspective, Meghmani Organics is rated mildly bearish. This assessment reflects recent price action and momentum indicators that suggest limited upward momentum and potential resistance levels. While short-term gains have been observed, the technical signals caution investors about possible price corrections or consolidation phases ahead. Technical analysis thus supports the overall cautious stance implied by the Sell rating.

Additional Market Insights

Meghmani Organics remains a microcap company within the Pesticides & Agrochemicals sector. Notably, domestic mutual funds currently hold no stake in the company, which may indicate a lack of institutional confidence or limited research coverage. This absence of significant institutional ownership can affect liquidity and market perception. Furthermore, the stock has consistently underperformed the BSE500 benchmark over the past three years, with a cumulative one-year return of -30.58%, underscoring the challenges faced by the company in delivering shareholder value.

Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!

  • - New Top 1% entry
  • - Market attention building
  • - Early positioning opportunity

Get Ahead - View Details →

Implications for Investors

Investors considering Meghmani Organics should interpret the Sell rating as a signal to exercise caution. The combination of weak long-term fundamentals, modest profitability, and a mildly bearish technical outlook suggests that the stock may face headwinds in delivering consistent returns. While the attractive valuation and recent positive financial trends offer some encouragement, these factors do not fully offset the risks associated with the company’s operational challenges and market underperformance.

Sector and Market Context

Operating within the Pesticides & Agrochemicals sector, Meghmani Organics competes in a market that is sensitive to regulatory changes, commodity price fluctuations, and agricultural demand cycles. The company’s microcap status further implies limited scale and potential vulnerability to market volatility. Investors should consider these sector-specific risks alongside the company’s individual performance metrics when evaluating the stock’s prospects.

Summary of Key Metrics as of 14 August 2026

To summarise, the latest data shows:

  • Mojo Score: 40.0, corresponding to a Sell grade
  • Operating profit CAGR over 5 years: -19.46%
  • Average Return on Equity: 7.13%
  • Short-term stock returns: +6.29% (1 day), +30.64% (1 month)
  • Long-term stock returns: -26.36% (1 year), underperforming BSE500 benchmark
  • Institutional ownership by domestic mutual funds: 0%

These figures collectively underpin the current recommendation and provide a comprehensive view of Meghmani Organics’ investment profile.

Conclusion

Meghmani Organics Ltd’s Sell rating reflects a balanced assessment of its current financial health, valuation, and market dynamics. While the company shows some signs of financial improvement and an attractive valuation, persistent fundamental weaknesses and technical caution advise prudence. Investors should carefully weigh these factors and monitor ongoing developments before committing capital to this stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News